Nucleo-cytoplasmic Transport Assay Service
Explore nucleocytoplasmic transport (NCT) with our advanced assay service. Our nucleocytoplasmic transport assay service provides researchers with a powerful, cost-effective, and highly sensitive tool to investigate the crucial role of nuclear-cytoplasmic transport in both fundamental biology and disease pathways. For further information regarding the products and services provided, project-specific consultation, and pricing, please submit an inquiry here.
Overview of NCT
![]() |
Nucleocytoplasmic transport, the vital exchange of proteins and RNA between the nucleus and cytoplasm, hinges on the functionality of the nuclear pore complex (NPC). Research increasingly indicates that disruptions in this transport process are prevalent in Amyotrophic Lateral Sclerosis (ALS), potentially resulting in the aberrant localization and impaired function of crucial proteins and RNA molecules. A striking example is the cytoplasmic aggregation of RNA-binding proteins such as TDP-43 and FUS, frequently observed in ALS patients. This accumulation may stem directly from compromised nucleocytoplasmic transport. |
Nucleocytoplasmic Transport Assays
- Real-Time Dynamic Monitoring
Our system employs a highly sensitive fluorescent reporter to track protein and RNA transport rates between the nucleus and cytoplasm in real time. This allows for the detection of subtle functional abnormalities, such as transport blockages caused by ALS-related TDP-43 aggregation, providing unparalleled insight into cellular dynamics.
- Pathological Model Validation
We've validated that dipeptide repeat sequences, like poly (GR) / poly (PR), generated from C9orf72 gene mutations, effectively mimic nucleocytoplasmic transport disruptions. Our model demonstrates a significant 50% reduction in nuclear import rates, offering a reliable platform for studying ALS/FTD and related neurodegenerative diseases.
- High-Throughput Drug Screening
Integrated with an automated imaging platform, our service supports large-scale screening of nucleocytoplasmic transport regulators and potential therapeutic compounds. This capability accelerates drug discovery for neurodegenerative diseases, enabling researchers to efficiently identify and validate promising candidates.
Applications
- Disease Mechanism Research
Delve into the complexities of ALS/FTD by analyzing nucleocytoplasmic transport defects stemming from TDP-43 aggregation and RanGAP1 dysregulation.
Investigate the RNA toxicity induced by C9orf72 repeat expansions and dissect the pathological impact of RAN translation products.
- Drug Target Validation
Evaluate the efficacy of nucleocytoplasmic transport inhibitors, such as small molecules targeting CRM1, in restoring normal cellular function.
Assess the potential of gene therapy approaches, including CRISPR editing, to correct nucleocytoplasmic transport abnormalities.
We offer researchers a streamlined, cost-effective, and highly sensitive platform to investigate the critical role of nucleocytoplasmic transport in both fundamental biological processes and disease pathogenesis. Whether your work focuses on basic discovery or translational applications, we are eager to collaborate with you to drive scientific advancement. Contact us today for tailored experimental solutions designed to meet your specific research needs.
Reference
- Vanneste, Joni, and Ludo Van Den Bosch. "The role of nucleocytoplasmic transport defects in amyotrophic lateral sclerosis." International Journal of Molecular Sciences 22.22 (2021): 12175. Distributed under Open Access license CC BY 4.0, without modification.
- iNeuMab™ Anti-Integrin αvβ8 BBB Shuttle Antibody (NRZP-1222-ZP1218) (Cat#: NRZP-1222-ZP1218)
- iNeuMab™ Anti-Tau Antibody (NRP-0422-P1686) (Cat#: NRP-0422-P1686)
- iNeuMab™ Anti-pTau Antibody (NRP-0422-P1719) (Cat#: NRP-0422-P1719)
- iNeuMab™ Anti-Alpha Synuclein Antibody (NRP-0422-P614) (Cat#: NRP-0422-P614)
- iNeuMab™ Anti-Tau Antibody (NRP-0422-P1760) (Cat#: NRP-0422-P1760)
- iNeuMab™ Anti-TREM2 BBB Shuttle Antibody (NRZP-1022-ZP4114) (Cat#: NRZP-1022-ZP4114)
- iNeuMab™ Anti-SEZ6 Antibody (NRP-0422-P515) (Cat#: NRP-0422-P515)
- iNeuMab™ Anti-Alpha Synuclein BBB Shuttle Antibody (NRZP-1022-ZP4050) (Cat#: NRZP-1022-ZP4050)
- iNeuMab™ Anti-Tau Antibody (NRP-0422-P1684) (Cat#: NRP-0422-P1684)
- iNeuMab™ Anti-CD32b Antibody (NRP-0422-P1803) (Cat#: NRP-0422-P1803)
- Rat Schwann Cells RSC96, Immortalized (Cat#: NCL-2108P21)
- Rat Microglia Cell Line HAPI, Immortalized (Cat#: NCL2110P015)
- Mouse Glioma Cell Line GL261 (Cat#: NCL-2108P28)
- Human Brain Astroblastoma U-87 MG (Cat#: NCL2110P117)
- Rat Immortalized Retinal Muller Cell Line rMC-1 (Cat#: NCL-2106-S93)
- Human Brain Vascular Adventitial Fibroblasts (Cat#: NCL-21P6-014)
- Mouse Microglia N9 (Cat#: NCL2110P073)
- Green Fluorescent Alpha-synuclein Cell Line (Cat#: NCL2110P209)
- Human Dental Pulp Stem Cells (Cat#: NRZP-1122-ZP113)
- iNeu™ Human Oligodendrocyte Progenitor Cells (OPCs) (Cat#: NCL-2103-P49)
- Human Poly ADP ribose polymerase,PARP Assay Kit (Cat#: NRZP-1122-ZP62)
- Human GFAP ELISA Kit [Colorimetric] (Cat#: NPP2011ZP383)
- Beta Amyloid (1-40), Aggregation Kit (Cat#: NRZP-0323-ZP199)
- Alpha Synuclein Aggregation Kit (Cat#: NRZP-1122-ZP15)
- Human Tau Aggregation Kit (Cat#: NRP-0322-P2173)
- Alpha-Synuclein Aggregation Assay Kit (Cat#: NRZP-1122-ZP37)
- Amyloid beta 1-42 Kit (Cat#: NRP-0322-P2170)
- Beta Amyloid (1-42), Aggregation Kit (Cat#: NRZP-0323-ZP200)
- VSV-eGFP (Cat#: NTA-2011-ZP20)
- Dextran, NHS Activated (Cat#: NRZP-0722-ZP124)
- AAV2 Full Capsids, Reference Standards (Cat#: NTC2101070CR)
- AAV2/9-hEF1a-fDIO-eNpHR 3.0-mCherry-WPRE-pA (Cat#: NTA-2012-ZP78)
- Lenti of Mouse synuclein, alpha (Snca) transcript variant (NM_001042451) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0864)
- Mouse Parkinson disease (autosomal recessive, early onset) 7 (Park7) (NM_020569) clone, Untagged (Cat#: NEP-0621-R0133)
- ABCA1 Antisense Oligonucleotide (NV-2106-P27) (Cat#: NV-2106-P27)
- Human presenilin 1 (PSEN1), transcript variant 2 (NM_007318) ORF clone, TurboGFP Tagged (Cat#: NEP-0421-R0140)
- Human apolipoprotein E (APOE) (NM_000041) ORF clone, Untagged (Cat#: NEP-0421-R0232)
- Tau Antisense Oligonucleotide (IONIS-MAPTRx) (Cat#: NV-2106-P29)
- Lenti of Human TAR DNA binding protein (TARDBP) (NM_007375) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0832)
- Rat Parkinson disease (autosomal recessive, juvenile) 2, parkin (Park2) (NM_020093) ORF clone/lentiviral particle, Myc-DDK Tagged (Cat#: NEP-0621-R0041)
- Human huntingtin-associated protein 1 (HAP1) transcript variant 2 (NM_177977) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0676)
- Human superoxide dismutase 3, extracellular (SOD3) (NM_003102) ORF clone, Untagged (Cat#: NEP-0521-R0808)
- NeuroBiologics™ Pig Cerebrospinal Fluid (Cat#: NRZP-0822-ZP498)
- NeuroBiologics™ Monkey Cerebrospinal Fluid (Cat#: NRZP-0822-ZP495)
- NeuroBiologics™ Mouse Cerebrospinal Fluid (Cat#: NRZP-0822-ZP497)
- NeuroBiologics™ Rat Cerebrospinal Fluid (Cat#: NRZP-0822-ZP496)
- NeuroBiologics™ Human Cerebrospinal Fluid (Cat#: NRZP-0822-ZP491)
- NeuroPro™ Anti-PON1 BBB Shuttle Protein (Cat#: NRZP-0423-ZP507)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP498)
- NeuroPro™ Anti-SGSH BBB Shuttle Protein (Cat#: NRZP-0423-ZP505)
- NeuroPro™ Anti-ASA BBB Shuttle Protein (Cat#: NRZP-0423-ZP504)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP501)
- NeuroPro™ Anti-IDS BBB Shuttle Protein (Cat#: NRZP-0423-ZP503)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP510)
- NeuroPro™ Anti-GDNF BBB Shuttle Protein (Cat#: NRZP-0423-ZP500)
- NeuroPro™ Anti-EPO BBB Shuttle Protein (Cat#: NRZP-0423-ZP508)
- NeuroPro™ Anti-Erythropoietin BBB Shuttle Protein (Cat#: NRZP-0423-ZP499)